Managing Diabetic Dyslipidemia: Aggressive Approach

No abstract is available for this paper.

• Publication year

  2009

• Venue

  The Journal of the American Osteopathic Association

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.7556/jaoa.2009.20002PMID 19451254
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.

  2008cited by this paper
• Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).

  2008cited by this paper
• Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.

  2008cited by this paper
• Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association.

  2007cited by this paper
• Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial.

  2007cited by this paper
• LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA).

  2007cited by this paper
• Gemfibrozil in the treatment of dyslipidemia: an 18-year mortality follow-up of the Helsinki Heart Study.

  2006cited by this paper
• Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: metaanalysis of randomised controlled trials

  2006cited by this paper
• Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.

  2006cited by this paper
• Antiatherogenic small, dense HDL—guardian angel of the arterial wall?

  2006cited by this paper
• Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

  2005cited by this paper
• Prevalence and control of dyslipidemia among persons with diabetes in the United States.

  2005cited by this paper
• Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).

  2005cited by this paper
• Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men: 13-Year Follow-Up Data From the Québec Cardiovascular Study

  2005cited by this paper
• Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study).

  2004cited by this paper
• Pharmacologic Lipid-Lowering Therapy in Type 2 Diabetes Mellitus: Background Paper for the American College of Physicians

  2004cited by this paper
• Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease: The Diabetes Atherosclerosis Intervention Study (DAIS)

  2003cited by this paper
• Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes.

  2002cited by this paper
• New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism

  2002cited by this paper
• Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.

  2001cited by this paper
• Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

  2000cited by this paper
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

  1999cited by this paper
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

  1999cited by this paper
• Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

  1998cited by this paper
• Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies

  1996cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes

  1989cited by this paper
• Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study.

  1988cited by this paper
• For Personal Use. Mass Reproduce Only with Permission from Mayo Clinic Proceedings. for Personal Use. Mass Reproduce Only with Permission from Mayo Clinic Proceedings. Simvastatin Vs Therapeutic Lifestyle Changes and Supplements: Randomized Primary Prevention Trial

  year unknowncited by this paper

• The effects of diabetes, hypertension and subsequent health control behavior on the survival of a Taiwan cohort aged over 50 years

  2024cites this paper
• A Comparison of Rehospitalization Risks on Diabetic and Non-Diabetic Patients after Recovery from Acute Coronary Syndrome

  2022cites this paper
• RSSDI consensus recommendations for dyslipidemia management in diabetes mellitus

  2022cites this paper
• Withaferin-A down-regulate enterohepatic circulation of bile acids: An insight from a hyperlipidemic rat model

  2020cites this paper
• Role of n-3 Fatty Acids on Bile Acid Metabolism and Transport in Dyslipidemia: A Review.

  2020cites this paper
• Healthy Life Expectancies by the Effects of Hypertension and Diabetes for the Middle Aged and Over in Taiwan

  2020cites this paper
• Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress

  2018cites this paper
• Effects of Caralluma russeliana stem extract on some physiological parameters in streptozotocin-induced diabetic male rats

  2018cites this paper
• Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress

  2018cites this paper
• Effect of Aloe vera on glycemic outcomes in patients with diabetes mellitus: a systematic review protocol.

  2017cites this paper
• Short-term administration of a small thyroxine dose to euthyroid type 2 diabetic patients improves the fasting lipoprotein profile#

  2017cites this paper
• Polypharmacology Shakes Hands with Complex Aetiopathology.

  2015cites this paper
• Effect of Atorvastatin on Pharmacology of Sitagliptin in Streptozotocin-Nicotinamide Induced Type-II Diabetes in Rats

  2014cites this paper
• Serum electrolytes and lipid profiles in non-insulin dependent diabetes mellitus patients

  2014cites this paper
• Effect of Simvastatin on the Pharmacodynamic Activity of Repaglinide in Rats/Rabbits

  2012cites this paper
• Cynara scolymus L. in Treatment of Hypercholesterolemic Type 2 Diabetic Patients: a Randomized Double-Blind Placebo-Controlled Clinical Trial

  2012cites this paper
• Diabetes and hyperlipidemia: A direct quantitative analysis—A direct analysis of the effects of insulin resistance on lipid levels in relation to atherosclerotic coronary artery disease

  2012cites this paper
• Influence of atorvastatin on the pharmacodynamic and pharmacokinetic activity of repaglinide in rats and rabbits

  2012cites this paper
• ATHEROGENIC DYSLIPIDEMIA IN DIABETES MELLITUS. PART 2: LIFESTYLE MODIFICATION, INFLUENCE OF ANTIHYPERGLYCEMIC PHARMACOTHERAPY

  2012cites this paper
• Anti-hyperglycemic and Anti-hypercholesterolemic Effects of Aloe vera Leaf Gel in Hyperlipidemic Type 2 Diabetic Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial

  2011cites this paper
• Uso de la metformina en la diabetes mellitus tipo II

  2011cites this paper